Elutia (ELUT) Free Cash Flow Growth (1y) (2020 - 2026)
Elutia (ELUT) Free Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -14.34% |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn | -2.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.83% |
| Dec 31, 2025 | -107.79% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | -92.45% |
| Mar 31, 2025 | -244.84% |
| Dec 31, 2024 | -35.73% |
| Sep 30, 2024 | 23.36% |
| Jun 30, 2024 | -75.02% |
| Mar 31, 2024 | 50.34% |
| Dec 31, 2023 | -69.18% |
| Sep 30, 2023 | 7.94% |
| Jun 30, 2023 | 77.42% |
| Mar 31, 2023 | 27.57% |
| Dec 31, 2022 | 16.11% |
| Sep 30, 2022 | -76.28% |
| Jun 30, 2022 | -1,113.18% |
| Mar 31, 2022 | -39.19% |
| Dec 31, 2021 | -16.94% |
| Sep 30, 2021 | -91.89% |
| Jun 30, 2021 | 77.53% |